Targeted Microbubbles for Ultrasound Mediated RNAi Therapy Shows Promise in Ovarian Cancer Treatment

Strategic Insights -

Current research has shown promising results for a novel method of RNA interference (RNAi) therapy using targeted microbubbles and ultrasound-targeted microbubble destruction (UTMD). This technology has the potential to provide an important therapeutic option for patients with ovarian cancer. By targeting the survivin gene, researchers were able to inhibit cell proliferation and induce apoptosis in ovarian cancer cells, leading to significant cell death.

Key Takeaways:

  • Researchers have developed a targeted microbubble agent that can be used in conjunction with UTMD to deliver RNAi therapy to ovarian cancer cells.
  • The targeted microbubbles were able to achieve high RNAi efficiency and induce significant cell apoptosis and cell proliferation inhibitory rate.
  • The use of UTMD mediated RNAi therapy showed promise in inhibiting the expression of the survivin gene and inducing apoptosis in ovarian cancer cells.
  • The study also found that the expression of apoptosis-related proteins, such as caspase-9 and caspase-3, was significantly increased after treatment.
  • The researchers concluded that this novel method of RNAi therapy represents a powerful, promising non-viral technology for tumor gene therapy and research.
  • The study used ovarian cancer cells, specifically A2780/DDP cells, which express LHRH receptors, to evaluate the effectiveness of the targeted microbubbles and UTMD mediated RNAi therapy.
  • The study demonstrated that the targeting of the survivin gene using shRNA was able to inhibit cell proliferation and induce apoptosis in ovarian cancer cells.

Statistics:

  • After transfection for 48 h, the expression of survivin mRNA was (0.36 +/- 0.036) and the expression of survivin protein was (0.05 +/- 0.02).
  • The cell proliferation inhibitory rates at 24, 48, and 72 h after treatment were (42.08 +/- 3.20)%, (54.60 +/- 1.02)%, and (74.25 +/- 2.14)% respectively.
  • The apoptosis rate was (28.99 +/- 2.70)%.
  • The expression of apoptosis-related protein caspase-9 was (0.95 +/- 0.09) and the expression of caspase-3 was (2.6 +/- 0.21).

Sources:

  • "Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells". Molecular Pharmaceutics, 2015;12(9):3137-3145.
  • American Chemical Society, 1155 16TH St, NW, Washington, DC 20036, USA.
  • Ohio State University, Dept. of Biomed Engn, Columbus, OH 43210, United States.